WallStreetZenWallStreetZen

NASDAQ: KROS
Keros Therapeutics Inc Stock Ownership - Who owns Keros Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Keros Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Orbimed Advisors LLCDirector2025-11-2174,465$17.75
$1.32MSell
Carl L. GordonDirector2025-11-21140,057$17.75
$2.49MSell
Carl L. GordonDirector2025-11-2174,465$17.75
$1.32MSell
Julius KnowlesDirector2025-11-21191,527$17.75
$3.40MSell
Julius KnowlesDirector2025-11-21130,494$17.75
$2.32MSell
Orbimed Advisors LLCDirector2025-11-21140,057$17.75
$2.49MSell
Pontifax Management 4 GP 2015 Ltd10% Owner2025-10-151,226,412$17.75
$21.77MSell
Pontifax Management 4 GP 2015 Ltd10% Owner2025-10-15155,262$17.75
$2.76MSell
Adar1 Capital Management LLC10% Owner2025-10-154,391,237$17.75
$77.94MSell
Adar1 Capital Management LLC10% Owner2025-10-15254,669$17.75
$4.52MSell

1 of 3

KROS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KROS insiders and whales buy or sell their stock.

KROS Shareholders

What type of owners hold Keros Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adar1 Capital Management LLC17.69%5,389,264$115.11MInstitution
Vanguard Group Inc8.92%2,718,777$58.07MInstitution
Blackrock Inc8.92%2,717,153$58.04MInstitution
Madison Avenue Partners LP8.89%2,708,218$57.85MInstitution
Western Standard LLC7.19%2,189,882$46.78MInstitution
Alon Lazarus6.68%2,036,140$43.49MInsider
Arkin Bio Ventures Limited Partnership6.61%2,013,102$43.00MInsider
Tang Capital Management LLC4.66%1,418,984$30.31MInstitution
D E Shaw Co Inc4.37%1,331,425$28.44MInstitution
Goldman Sachs Group Inc4.35%1,325,483$28.31MInstitution

1 of 3

KROS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KROS79.60%20.40%Net SellingNet Selling
MGTX56.35%43.65%Net SellingNet Selling
DBVT3.85%19.90%Net SellingNet Selling
PRME44.61%55.39%Net Buying
ENGN61.01%28.37%
View Top Biotech Stocks

Keros Therapeutics Stock Ownership FAQ

Who owns Keros Therapeutics?

Keros Therapeutics (NASDAQ: KROS) is owned by 115.80% institutional shareholders, 29.68% Keros Therapeutics insiders, and 0.00% retail investors. Alon Lazarus is the largest individual Keros Therapeutics shareholder, owning 2.04M shares representing 6.68% of the company. Alon Lazarus's Keros Therapeutics shares are currently valued at $42.82M.

If you're new to stock investing, here's how to buy Keros Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.